1993
DOI: 10.1097/00132586-199310000-00028
|View full text |Cite
|
Sign up to set email alerts
|

Long-term Follow-up of Non-A, Non-B (Type C) Post-transfusion Hepatitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
81
0
3

Year Published

1999
1999
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 63 publications
(89 citation statements)
references
References 0 publications
5
81
0
3
Order By: Relevance
“…Progressive liver disease was found in 50% of these individuals and 20% had liver cirrhosis. This rate of progression is in contrast to some previous reports7 11 27 but consistent with data from Tremolada and colleagues8 and Tong and colleagues 9…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Progressive liver disease was found in 50% of these individuals and 20% had liver cirrhosis. This rate of progression is in contrast to some previous reports7 11 27 but consistent with data from Tremolada and colleagues8 and Tong and colleagues 9…”
Section: Discussionsupporting
confidence: 92%
“…4 Chronic HCV infection can run a mild course with little or no morbidity but the long term sequelae have been found to differ widely in different studies 5-11. Progression to cirrhosis will occur in up to 30% of all cases5-8 and the risk of developing hepatocellular carcinoma (HCC) after longstanding infection is clearly increased 812 13 The reason why some people and not others develop severe disease may be determined by the effect of a large number of both host and viral variables that can influence disease progression.…”
mentioning
confidence: 99%
“…We modified the front end of the model to include patients with normal alanine aminotransferase (ALT) levels and chronic HCV infection, adding the assumption of non-progression of the disease for these patients. Table 1 shows the probabilities of transition between each state [4,[6][7][8][9][10][11][12][13][14][15][16][17][18]. The model was validated by predicting the 5-year survival rate of a cohort of patients with compensated cirrhosis.…”
Section: Decision Analytic Model: Markov Modelmentioning
confidence: 99%
“…More than 10 years after the discovery of HCV, however, some aspects of the natural history of hepatitis C remain unclear, and there is a need to reconcile the indolent or slowly progressive disease reported in many prospective studies with the well-documented serious outcomes, such as cirrhosis and hepatocellular carcinoma, observed in tertiary-care centers [1][2][3][4][5][6][7][8]. The varying rates of progression of HCV infection to cirrhosis are thought to be the effect of both host-and virus-associated variables, but the long duration of the disease and the fact that many patients have been treated have made prospective studies difficult.…”
mentioning
confidence: 99%